QUEBEC CITY, Sept. 20 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy
and oncology, today announced that its President and CEO, David J. Mazzo,
Ph.D., will present a Company overview at the UBS Global Life Sciences
Conference on Thursday, September 27, 2007 at 10:00 a.m. Eastern, in the
Ballroom E of the Grand Hyatt Hotel in New York City.
A live webcast of this presentation will be available on AEterna
Zentaris' website at www.aeternazentaris.com in the Investors section. A
replay will also be available for a period of 30 days on the Company's
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization.
News releases and additional information are available at
For further information:
For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475,
email@example.com; Paul Burroughs, Media Relations, (418)
652-8525 ext. 406, firstname.lastname@example.org